Published in Clin Exp Immunol on March 01, 2006
Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy. J Virol (2008) 1.79
Immunologic and virologic events in early HIV infection predict subsequent rate of progression. J Infect Dis (2010) 1.53
CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection. J Immunol (2008) 1.31
Central memory CD8+ T cells appear to have a shorter lifespan and reduced abundance as a function of HIV disease progression. J Immunol (2008) 1.24
Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7Ralpha on central and effector memory CD4+ and CD8+ T cell subsets. Clin Exp Immunol (2008) 1.14
Association between peripheral T-Lymphocyte activation and impaired bone mineral density in HIV-infected patients. J Transl Med (2013) 1.03
Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway. J Virol (2010) 1.00
Interleukin-7 compartmentalizes its receptor signaling complex to initiate CD4 T lymphocyte response. J Biol Chem (2010) 0.99
Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1+ patients. J Transl Med (2012) 0.86
IL-2 receptor gamma chain cytokines differentially regulate human CD8+CD127+ and CD8+CD127- T cell division and susceptibility to apoptosis. Int Immunol (2008) 0.85
Dynamic analysis of CD127 expression on memory CD8 T cells from patients with chronic hepatitis B during telbivudine treatment. Virol J (2010) 0.84
T-Cell Signaling in HIV-1 Infection. Open Virol J (2013) 0.83
Increased bone marrow interleukin-7 (IL-7)/IL-7R levels but reduced IL-7 responsiveness in HIV-positive patients lacking CD4+ gain on antiviral therapy. PLoS One (2010) 0.83
Loss of CD127 & increased immunosenescence of T cell subsets in HIV infected individuals. Indian J Med Res (2011) 0.83
Decreased IL-7 responsiveness is related to oxidative stress in HIV disease. PLoS One (2013) 0.83
CD8+ T-cell interleukin-7 receptor alpha expression as a potential indicator of disease status in HIV-infected children. PLoS One (2008) 0.82
Interleukin-7 enhances proliferation responses to T-cell receptor stimulation in naïve CD4+ T cells from human immunodeficiency virus-infected persons. J Virol (2007) 0.82
Pegylated interferon α enhances recovery of memory T cells in e antigen positive chronic hepatitis B patients. Virol J (2012) 0.80
HIV infection of thymocytes inhibits IL-7 activity without altering CD127 expression. Retrovirology (2011) 0.76
In vitro HIV Type 1 infection indirectly alters CD127 expression on CD8(+) T cells. AIDS Res Hum Retroviruses (2011) 0.76
Expression of the IL-7 receptor alpha-chain is down regulated on the surface of CD4 T-cells by the HIV-1 Tat protein. PLoS One (2014) 0.75
IL-7 receptor recovery on CD8 T-cells isolated from HIV+ patients is inhibited by the HIV Tat protein. PLoS One (2014) 0.75
Generalized Liver- and Blood-Derived CD8+ T-Cell Impairment in Response to Cytokines in Chronic Hepatitis C Virus Infection. PLoS One (2016) 0.75
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8(+) T Cell Responses to Chronic Viral Infections and Cancer. Front Immunol (2017) 0.75
Transcriptional regulation of the IL-7Rα gene by dexamethasone and IL-7 in primary human CD8 T cells. Immunogenetics (2016) 0.75
American tegumentary leishmaniasis: T-cell differentiation profile of cutaneous and mucosal forms-co-infection with Trypanosoma cruzi. Med Microbiol Immunol (2016) 0.75
Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol (2004) 17.54
Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol (2003) 15.51
Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo. Nat Immunol (2000) 12.81
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med (2002) 10.03
Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med (1997) 8.59
Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature (2001) 7.90
Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity (2003) 6.19
Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS (2003) 5.85
Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med (2001) 3.69
Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity (2004) 3.67
Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol (2004) 3.20
Interleukin-7: from bench to clinic. Blood (2002) 3.01
Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals. J Immunol (2005) 2.87
Turnover of lymphocytes and conceptual paradigms in HIV infection. J Clin Invest (2003) 1.69
Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV. AIDS (2005) 1.40
Effects of exogenous interleukin-7 on human thymus function. Blood (2002) 1.38
Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation. J Virol (2000) 1.38
Interleukin-7 receptor expression on CD8(+) T cells is reduced in HIV infection and partially restored with effective antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 1.33
Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection. Immunol Lett (1998) 1.04
Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy. Proc Natl Acad Sci U S A (1998) 1.03
Features of 'CD4-exploders', HIV-positive patients with an optimal immune reconstitution after potent antiretroviral therapy. AIDS (2002) 0.98
Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential. Eur Cytokine Netw (2005) 0.98
Dysregulation of interleukin-7 receptor may generate loss of cytotoxic T cell response in human immunodeficiency virus type 1 infection. Eur J Immunol (1994) 0.96
Defective interleukin-2-dependent STAT5 signalling in CD8 T lymphocytes from HIV-positive patients: restoration by antiretroviral therapy. AIDS (2004) 0.86
HIV infection: pre-highly active antiretroviral therapy IL-7 plasma levels correlate with long-term CD4 cell count increase after treatment. AIDS (2004) 0.81
IL-7 and Flt-3L plasma levels are increased during highly active antiretroviral therapy-associated IL-2 therapy. AIDS (2004) 0.79
Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24. Ann Rheum Dis (2013) 2.99
Threonine locus of Escherichia coli K-12: genetic structure and evidence for an operon. J Bacteriol (1974) 2.52
Towards realistic estimates of HCV incidence in Egypt. J Viral Hepat (2012) 2.28
Immunosuppressive factor(s) specific for L-glutamic acid50-L-tyrosine50 (GT) II. Presence of I-J determinants on the GT-suppressive factor. J Exp Med (1977) 2.12
Immunosuppressive factor(s) specific for L-glutamic acid50-L-tyrosine50 (GT). III. Generation of suppressor T cells by a suppressive extract derived from GT-primed lymphoid cells. J Exp Med (1977) 2.08
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis (2004) 2.06
Mapping of the structural genes of the three aspartokinases and of the two homoserine dehydrogenases of Escherichia coli K-12. J Bacteriol (1974) 1.81
IL-4 plays a dominant role in the differential development of Tho into Th1 and Th2 cells. J Immunol (1992) 1.75
Higher clearance of hepatitis C virus infection in females compared with males. Gut (2006) 1.57
Further analysis of interleukin-2 receptor subunit expression on the different human peripheral blood mononuclear cell subsets. Blood (1998) 1.56
HCV burden of infection in Egypt: results from a nationwide survey. J Viral Hepat (2012) 1.53
Hemolysis and schistocytosis in the emergency department: consider pseudothrombotic microangiopathy related to vitamin B12 deficiency. QJM (2013) 1.50
[Recommendations for the treatment of prostate cancer in the elderly man: A study by the oncology committee of the French association of urology]. Prog Urol (2009) 1.40
New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen Med (2007) 1.39
Factors associated with HIV-1 infection among sex workers of Addis Ababa, Ethiopia. AIDS (2001) 1.36
Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut (2006) 1.34
Improved method for the simultaneous determination of d4T, 3TC and ddl intracellular phosphorylated anabolites in human peripheral-blood mononuclear cells using high-performance liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom (2002) 1.31
A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight. Mol Psychiatry (2012) 1.26
Monoclonal antibodies identify three epitope clusters on the mouse p55 subunit of the interleukin 2 receptor: relationship to the interleukin 2-binding site. Eur J Immunol (1987) 1.25
Plasmacytoid dendritic cells reduce HIV production in elite controllers. J Virol (2012) 1.09
Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor. Br J Pharmacol (2009) 1.07
The idiotypic network and the internal image: possible regulation of a germ-line network by paucigene encoded Ab2 (anti-idiotypic) antibodies in the GAT system. EMBO J (1985) 1.05
Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trial. HIV Med (2009) 1.05
Immunosuppressive factor(s) specific for L-glutamic acid50-L-tyrosine50 (GT). I. Production, characterization, and lack of H-2 restriction for activity in recipient strain. J Immunol (1977) 1.04
Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy. Proc Natl Acad Sci U S A (1998) 1.03
UV-treated polystyrene microtitre plates for use in an ELISA to measure antibodies against synthetic peptides. J Immunol Methods (1991) 1.01
HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt. Gut (2010) 1.00
HIV type 1 subtype C in Addis Ababa, Ethiopia. AIDS Res Hum Retroviruses (1997) 0.99
Antigen-specific helper T-cell clone supernatant is sufficient to induce both polyclonal proliferation and differentiation of small resting B lymphocytes. Proc Natl Acad Sci U S A (1984) 0.98
Immunosuppressive factor(s) specific for L-glutamic acid50-L-tyosine50. IV. In vitro activity and immunochemical properties. Eur J Immunol (1977) 0.98
Monoclonal anti-GAT antibodies with different fine specificities express the same public idiotype. Mol Immunol (1982) 0.98
[Splenic rupture in infectious disease: splenectomy or conservative treatment? Report of three cases]. Rev Med Interne (2002) 0.94
Overview of revised measures to prevent malaria transmission by blood transfusion in France. Vox Sang (2008) 0.94
Genetic control of the immune response to the GAT terpolymer. I. Interstrain and interspecies cross-reactive idiotype. Ann Immunol (Paris) (1979) 0.94
Contribution of the H- and L-chains and of the binding site to the idiotypic specificities of mouse anti-GAT antibodies. Mol Immunol (1982) 0.94
Somatic diversification in the heavy chain variable region genes expressed by human autoantibodies bearing a lupus-associated nephritogenic anti-DNA idiotype. Proc Natl Acad Sci U S A (1994) 0.94
Structural bases for public idiotypic specificities of monoclonal antibodies directed against poly(Glu60Ala30Tyr10) and poly(Glu60Ala40) random copolymers. Proc Natl Acad Sci U S A (1983) 0.93
Internalization of interleukin 2 (IL-2) by high affinity IL-2 receptors is required for the growth of IL-2-dependent T cell lines. J Immunol (1987) 0.93
Analysis of human VH gene repertoire expression in peripheral CD19+ B cells. Immunogenetics (1995) 0.92
Increase in tuberculosis incidence among the staff working at the Tuberculosis Demonstration and Training Centre in Addis Ababa, Ethiopia: a retrospective cohort study (1989-1998). Int J Tuberc Lung Dis (2002) 0.92
[Kallikrein inhibition of the expression of the lymphocyte E rosette receptor. Prevention of this effect by alpha-2-macroglobulin]. C R Acad Sci III (1985) 0.91
Identification of a site for a cohort study on natural history of HIV infection in Ethiopia. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.91
Diagnosis, management and outcome of Candida endocarditis. Clin Microbiol Infect (2012) 0.91
Polymorphism in the proximal promoter region of the perforin gene and its impact on the course of HIV infection. Int J Immunogenet (2006) 0.91
Atovaquone plus proguanil versus halofantrine for the treatment of imported acute uncomplicated Plasmodium falciparum malaria in non-immune adults: a randomized comparative trial. Am J Trop Med Hyg (2001) 0.91
Lack of intermediate-affinity interleukin-2 receptor in mice leads to dependence on interleukin-2 receptor alpha, beta and gamma chain expression for T cell growth. Eur J Immunol (1996) 0.90
Challenging the model for induction of metallothionein gene expression. Biochimie (2006) 0.89
[Splenic hematoma during infectious mononucleosis: non-operative treatment]. Presse Med (1998) 0.88
p55 IL-2 receptor mRNA precursors in murine T lymphocyte nuclei. J Immunol (1988) 0.88
Predictive factors of severe disease secondary to falciparum malaria among travelers. Pathol Biol (Paris) (2010) 0.86
Human immunodeficiency virus-1 envelope glycoproteins and anti-CD4 antibodies inhibit interleukin-2-induced Jak/STAT signalling in human CD4 T lymphocytes. Clin Exp Immunol (2003) 0.85
Selective variations in vivo of VH3 and VH1 gene family expression in peripheral B cell IgM, IgD and IgG during HIV infection. Eur J Immunol (1995) 0.85
IL-2-dependent expression of genes involved in cytoskeleton organization, oncogene regulation, and transcriptional control. J Immunol (1999) 0.85
[Recommendations Onco-Urology 2010: Prostate cancer]. Prog Urol (2010) 0.85
[Teaching transfusion medicine research in the francophone world]. Transfus Clin Biol (2009) 0.84
[Risk factors for incident cervical intraepithelial neoplasia (CIN) among HIV-infected women: a prospective study]. J Gynecol Obstet Biol Reprod (Paris) (2006) 0.83
Quality assessment of seven types of fresh-frozen plasma leucoreduced by specific plasma filtration. Vox Sang (2003) 0.83
Clonotypic dominance and variable gene elements of pathogenic anti-DNA autoantibodies from a single patient with lupus. Scand J Immunol (1994) 0.83
Restriction of primary responses to the IgG class and dependency of IgM responses on secondary immunization for the copolymers of L-glutamic acid, L-tyrosine, and L-alanine. J Exp Med (1977) 0.83
Molecular characterization of human monoclonal antibodies specific for several HIV proteins: analysis of the VH3 family expression. Immunol Lett (1996) 0.83
Interleukin-2 receptor beta and gamma chain dysregulation during the inhibition of CD4 T cell activation by human immunodeficiency virus-1 gp120. Eur J Immunol (1997) 0.83
Immune response against poly(Glu60,Ala30,Tyr10) (GAT): immunization with monoclonal anti-idiotypic antibodies leads to the predominant stimulation of idiotypically similar immunoglobulins with anti-GAT activity. Eur J Immunol (1985) 0.83
[Comparison of techniques used to screen blood donations for malaria antibodies]. Med Trop (Mars) (2003) 0.83
[Aortitis after G-CSF injections]. Rev Med Interne (2004) 0.83
Morbidity associated with long-term use of totally implantable ports in patients with AIDS. Clin Infect Dis (1999) 0.82
Impact of environmental housing conditions on the emotional responses of mice deficient for nociceptin/orphanin FQ peptide precursor gene. Behav Brain Res (2003) 0.82
Expression of the IL-2 receptor gamma subunit in resting human CD4 T lymphocytes: mRNA is constitutively transcribed and the protein stored as an intracellular component. Int Immunol (1997) 0.82
IL-2-induced tumor necrosis factor (TNF)-beta expression: further analysis in the IL-2 knockout model, and comparison with TNF-alpha, lymphotoxin-beta, TNFR1 and TNFR2 modulation. Int Immunol (2001) 0.82
New radioimmunoassay for the detection of free IL2 receptor in supernatants of murine helper and cytotoxic T-cell lines. Ann Inst Pasteur Immunol (1986) 0.82
Evidence for negative regulation of T cell growth by low affinity interleukin 2 receptors. J Immunol (1987) 0.82
Recent changes in the management of primary HIV-1 infection: results from the French PRIMO cohort. HIV Med (2004) 0.82
[Hemophagocytic lymphohistiocytosis]. Rev Med Interne (2012) 0.81
Quantitative clonal analysis of the B cell repertoire in human lupus. Cell Immunol (1991) 0.81
IL-2-dependent proliferation of murine T cells requires expression of both the p55 and p70 subunits of the IL-2 receptor. J Immunol (1990) 0.81
The first alpha helix of interleukin (IL)-2 folds as a homotetramer, acts as an agonist of the IL-2 receptor beta chain, and induces lymphokine-activated killer cells. J Exp Med (2000) 0.81
Rapid effect of interleukin-2 therapy in human immunodeficiency virus-infected patients whose CD4 cell counts increase only slightly in response to combined antiretroviral treatment. J Infect Dis (2001) 0.81
Genetic control of the immune response to the L-Glu60-L-Ala30-L-Tyr10 (GAT) terpolymer. V. Three types of idiotypic specificities on BALB/c anti-GAT antibodies. Eur J Immunol (1981) 0.80
Genetic control of the immune response to the terpolymer L-glutamic acid 60-L-alanine 30-L-tyrosine10 (GAT). III. Restricted heterogeneity of the anti-GAT response from BALB/c responder mice. Eur J Immunol (1979) 0.80
Transgene expression, but not gene delivery, is improved by adhesion-assisted lipofection of hematopoietic cells. Gene Ther (1999) 0.80
Anti-idiotypic antibodies to human anti-gp120 antibodies bind recombinant and cellular human CD4. Eur J Immunol (1991) 0.80
Myelofibrosis in a patient with pachydermoperiostosis. Clin Exp Dermatol (2005) 0.80
Unstimulated human CD4 lymphocytes express a cytoplasmic immature form of the common cytokine receptor gamma-chain. J Immunol (2001) 0.80
Public and individual idiotopes in the anti-poly(Glu60, Ala30, Tyr10) response: analysis by monoclonal antibodies. Eur J Immunol (1983) 0.80
Differential regulation of interleukin-12- and interleukin-15-induced natural killer cell activation by interleukin-4. Eur J Immunol (1996) 0.80
Dimorphic effects of leptin on the circadian and hypocretinergic systems of mice. J Neuroendocrinol (2011) 0.80
Reproducibility of liver stiffness measurements in hepatitis C virus (HCV)-infected patients in Egypt. J Viral Hepat (2011) 0.79
Expression of GAT-715 idiotype by GAT-specific plaque-forming cells from various strains of mice. Cell Immunol (1981) 0.79
The internal image and the structural idiotypic network (Ab1, Ab2, Ab3) in the GAT system. Ann Inst Pasteur Immunol (1985) 0.79
Analysis of a major rat idiotype associated with Anti-GAT antibodies. Mol Immunol (1982) 0.79
Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt. J Viral Hepat (2014) 0.79
IgG-binding factors. Methods Enzymol (1985) 0.79
A structural basis for the internal image in the idiotypic network: antibodies against synthetic Ab2-D regions cross-react with the original antigen. Ann Inst Pasteur Immunol (1986) 0.79
[The blood donors' haemovigilance in France]. Transfus Clin Biol (2013) 0.79